Annual report
4360.TEDINET S100O90G
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 37
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥740m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥881m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥940m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥13.6bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥3.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.8bn | at 2021-03-31 | Cons. | Net assets |
| Cash and deposits | ¥2.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥714m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥422m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥200m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥90.52 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,300.81 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 75.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 241 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥317m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | ¥173m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥188m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥242m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥174m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥10.6bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥79m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥10.5bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥700m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥22.05 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥7.5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,324.77 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 99.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,625,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7 | at 2022-03-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥70m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥107m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥4.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.0bn |
| Fine Chemical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥316m |
| Fine Chemical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥200m |
| Fine Chemical Businessreportable segment | employees | at 2022-03-31 | 99 pure |
| Fine Chemical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | segment assets | at 2022-03-31 | ¥5.0bn |
| Fine Chemical Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥794m |
| Flame Retardants Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥196m |
| Flame Retardants Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| Flame Retardants Businessreportable segment | employees | at 2022-03-31 | 45 pure |
| Flame Retardants Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Flame Retardants Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥831m |
| Health Support Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥80m |
| Health Support Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥29m |
| Health Support Businessreportable segment | employees | at 2022-03-31 | 15 pure |
| Health Support Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | segment assets | at 2022-03-31 | ¥773m |
| Health Support Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥126m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥593m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥343m |
| —segment total | employees | at 2022-03-31 | 159 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | segment assets | at 2022-03-31 | ¥8.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 838
| Item | Context | Value | Unit |
|---|---|---|---|
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 22.05 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.992 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.017 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24.0 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.340 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 7 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.028 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.443 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36769-000FineChemicalBusinessReportableSegmentsMember | 99 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 45 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36769-000HealthSupportBusinessReportableSegmentsMember | 15 | |
| Number of employees | CurrentYearInstant_ReportableSegmentsMember | 159 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 82 | |
| Number of employees | CurrentYearInstant | 241 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 7 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 43.2 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 12.7 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7248294 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 7 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 7 | |
| Research and development expenses research and development activities | CurrentYearDuration | 290000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E36769-000FineChemicalBusinessReportableSegmentsMember | 165000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 113000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E36769-000HealthSupportBusinessReportableSegmentsMember | 12000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 664000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36769-000FineChemicalBusinessReportableSegmentsMember | 316000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 196000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36769-000HealthSupportBusinessReportableSegmentsMember | 80000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8625000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8625000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 8625000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 8625000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 7 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 18 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 85 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 10 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 8 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 2861 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 2989 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 6292 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 2785 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 38258 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 82 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 106 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 38534 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 86057 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |